Biblio Discovery — Demo Discovery Service

82 results for "Chesson Harrell W"

Showing 1–20 · 0.76 seconds · RSS

  1. Journal Article Full text

    Cost effectiveness of one to one STI prevention interventions

    Chesson, Harrell W

    Sex Transm Infect · 2007 · English · PubMed Central

    A cost effective use of public health resources

  2. Journal Article Full text

    Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States

    Koski Kathryn; Collins Dayne; Chesson Harrell W

    Cost Effectiveness and Resource Allocation, Vol. 6 No. 1 · 2008 · English · DOAJ Scopus

    Abstract Background Sexually transmitted infection (STI) prevention programs can mitigate the health and economic burden of STIs. A tool to estimate the economic benefits of STI programs could prove useful to STI program personnel. Methods We developed formulas that can be applied to estimate the…

    Also available at: PubMed Central

  3. Journal Article Full text

    Relative Impact of Different Strategies for Allocating Federal Funds for Syphilis Prevention

    Chesson, Harrell W.; Owusu-Edusei, Kwame

    Sex Transm Dis · 2018 · English · PubMed Central

    BACKGROUND: Improvements in resource allocation can increase the benefits of federally funded sexually transmitted disease (STD) prevention activities. The purpose of this study was to illustrate how different strategies for allocating federal funds to subnational districts for syphilis prevention…

  4. Journal Article Full text

    Recent Changes in Prevention Funding to Areas With High Racial and Ethnic Disparities in Sexually Transmitted Disease Rates

    Williams, Austin M.; Chesson, Harrell W.

    Sex Transm Dis · 2018 · English · PubMed Central

    We examined changes in federal sexually transmitted disease funding allocations to areas with high racial/ethnic disparities in sexually transmitted diseases after the implementation of a funding formula in 2014. The funding formula increased prevention funding allocations to areas with high…

  5. Journal Article Full text

    The Estimated Lifetime Medical Cost of Syphilis in the United States

    Chesson, Harrell W.; Peterman, Thomas A.

    Sex Transm Dis · 2021 · English · PubMed Central

    BACKGROUND: The purpose of this study was to estimate the cost of syphilis in the United States, in terms of the average lifetime direct medical cost per infection. METHODS: We used a decision tree model of the natural history of syphilis. The model allowed for numerous possible outcomes of…

  6. Journal Article Full text

    The cost-effectiveness of the WINGS intervention: a program to prevent HIV and sexually transmitted diseases among high-risk urban women

    Hennessy Michael; Greenberg Judith B; Chesson Harrell W

    BMC Infectious Diseases, Vol. 2 No. 1 · 2002 · English · DOAJ Scopus

    Abstract Background We evaluated the cost-effectiveness of the WINGS project, an intervention to prevent HIV and other sexually transmitted diseases among urban women at high risk for sexual acquisition of HIV. Methods We used standard methods of cost-effectiveness analysis. We conducted a…

    Also available at: PubMed Central

  7. Journal Article Full text

    Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013

    Patel, Chirag G.; Chesson, Harrell W.; Tao, Guoyu

    Sex Transm Dis · 2016 · English · PubMed Central

    OBJECTIVE: To estimate the percentage of young, sexually active Medicaid-insured women who were tested for chlamydia by age, race/ethnicity, and history of sexually transmitted disease (STD) diagnosis. METHODS: We used the medical diagnostic and procedural codes from Truven Health MarketScan…

  8. Journal Article Full text

    HPV vaccine status and sexual behavior among young sexually-active women in the US: evidence from the National Health and Nutrition Examination Survey, 2007–2014

    Leidner, Andrew J.; Chesson, Harrell W.; Talih, Makram

    Health Econ Policy Law · 2019 · English · PubMed Central

    Concern has been expressed that human papillomavirus (HPV) vaccination programs might promote risky sexual behavior through mechanisms such as risk compensation, behavioral disinhibition, or perceived endorsement of sexual activity. This study assesses whether HPV vaccination status is associated…

  9. Journal Article Full text

    Trends in costs of routinely recommended vaccines in the United States, 2001–2023

    Kaul, RajReni; Leidner, Andrew J.; Chesson, Harrell W.

    Vaccine · 2025 · English · PubMed Central

    OBJECTIVES: Economic models assessing vaccinations commonly assume that inflation-adjusted vaccine costs are constant over time. This study assessed this assumption using historical vaccine cost data. METHODS: Private sector and CDC contracted vaccine cost data (2001–2023) were collected from the…

  10. Journal Article Full text

    Analyzing the costs and impact of the TakeMeHome program, a public-private partnership to deliver HIV self-test kits in the United States

    Shrestha, Ram K.; Hecht, Jennifer; Chesson, Harrell W.

    J Acquir Immune Defic Syndr · 2024 · English · PubMed Central

    BACKGROUND: HIV testing is as an entry point to access HIV care and prevention services. Building Healthy Online Communities (BHOC) developed a website (TakeMeHome.org) where participants can order HIV home test kits. The purpose of this study was to analyze the costs and impact of the TakeMeHome…

  11. Journal Article Full text

    Impacts of Federal Prevention Funding on Reported Gonorrhea and Chlamydia Rates

    Williams, Austin M.; Kreisel, Kristen; Chesson, Harrell W.

    Am J Prev Med · 2019 · English · PubMed Central

    INTRODUCTION: The Centers for Disease Control and Prevention allocates funds annually to jurisdictions nationwide for sexually transmitted infection prevention activities. The objective of this study was to assess the effectiveness of federal sexually transmitted infection prevention funding for…

  12. Journal Article Full text

    HIV Infections and Associated Costs Attributable to Syphilis Coinfection Among African Americans

    Chesson, Harrell W.; Pinkerton, Steven D.; Voigt, Richard et al.

    Am J Public Health · 2003 · English · PubMed Central

    Objectives. We estimated the number and cost of syphilis-attributable HIV cases among African Americans. Methods. A mathematical model of HIV transmission was used to estimate the number of partnerships consisting of HIV-discordant African Americans in which infectious syphilis was present and the…

  13. Journal Article Full text

    Cost-effectiveness of Human Papillomavirus Vaccination in the United States

    Chesson, Harrell W.; Ekwueme, Donatus U.; Saraiya, Mona et al.

    Emerg Infect Dis · 2008 · English · PubMed Central

    We describe a simplified model, based on the current economic and health effects of human papillomavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old girls in the United States. Under base-case parameter values, the estimated cost per quality-adjusted life year gained…

  14. Journal Article Full text

    The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States

    Chesson, Harrell W.; Dunne, Eileen F.; Hariri, Susan et al.

    Sex Transm Dis · 2014 · English · PubMed Central

    BACKGROUND: Estimates of the lifetime probability of acquiring human papillomavirus (HPV) can help to quantify HPV incidence, illustrate how common HPV infection is, and highlight the importance of HPV vaccination. METHODS: We developed a simple model, based primarily on the distribution of…

  15. Journal Article Full text

    Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine

    Chesson, Harrell W.; Laprise, Jean-François; Brisson, Marc et al.

    J Infect Dis · 2016 · English · PubMed Central

    Background. We estimated the potential impact and cost-effectiveness of providing 3-doses of nonavalent human papillomavirus (HPV) vaccine (9vHPV) to females aged 13–18 years who had previously completed a series of quadrivalent HPV vaccine (4vHPV), a strategy we refer to as “additional 9vHPV…